Cargando…

The present evidence summary of SARS-CoV-2 vaccine-associated liver injury: A rapid systematic review

Detalles Bibliográficos
Autores principales:	Li, Zheng, Hu, Yue, Jiang, Yunlan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091864/ https://www.ncbi.nlm.nih.gov/pubmed/36906108 http://dx.doi.org/10.1016/j.jhep.2023.02.038

Ejemplares similares

Liver injury following SARS-CoV-2 vaccination: A multicenter case series
por: Shroff, Hersh, et al.
Publicado: (2022)

Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination.
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient
por: Dumortier, Jérôme
Publicado: (2022)

Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination
por: Lee, Soon Kyu, et al.
Publicado: (2022)

Glomerular endothelial injury following vaccination for SARS-CoV-2
por: Tanemoto, Masayuki, et al.
Publicado: (2021)

Liver injury with autoimmune features after vaccination against SARS-CoV-2: The verdict is still open
por: Ferronato, Marco, et al.
Publicado: (2023)

Unexplained liver test elevations after SARS-CoV-2 vaccination
por: Guardiola, John, et al.
Publicado: (2022)

No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease
por: Biquard, Louise, et al.
Publicado: (2020)

Living evidence for SARS-CoV-2()
por: Santillan-Garcia, A.
Publicado: (2021)

Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!
por: Guarino, Maria, et al.
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease’
por: Ji, Dong, et al.
Publicado: (2020)

SARS-CoV-2 infection presenting with hematochezia
por: Guotao, L., et al.
Publicado: (2020)

Answering the call to action: rapid implementation of an in-center hemodialysis SARS-CoV-2 vaccination program
por: Gleeson, Sarah, et al.
Publicado: (2021)

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
por: Zhang, Na-Na, et al.
Publicado: (2022)

Reply to: “Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!”
por: Rabinowich, Liane, et al.
Publicado: (2022)

Poor Response to Inactivated SARS-CoV-2 Vaccine in Patients With Chronic Liver Disease
por: Cao, Huanhuan, et al.
Publicado: (2022)

SARS-CoV-2 and the myths about vaccination()
por: Travezaño-Cabrera, Aaron, et al.
Publicado: (2021)

Immunophenotyping of SARS-CoV-2 and vaccine design
por: Cimolai, Nevio
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Patterns and prediction of liver injury with persistent cholestasis in survivors of severe SARS-CoV-2 infection
por: Nayagam, Jeremy S, et al.
Publicado: (2021)

Commentary: SARS-CoV-2 vaccines and cancer patients
por: Corti, C., et al.
Publicado: (2021)

Impact of SARS-CoV-2 vaccines on the nervous system
por: Scorza, Fulvio Alexandre, et al.
Publicado: (2022)

Graves’ disease following SARS-CoV-2 vaccination
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2021)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

SARS‐CoV‐2 vaccinations can trigger polyradiculitis
por: Finsterer, Josef, et al.
Publicado: (2022)

Subacute thyroiditis and different SARS-CoV-2 vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS-CoV-2 infection presenting as acute acalculous cholecystitis
por: Hurtado, Fernando Berdugo, et al.
Publicado: (2021)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

Rapid antigen tests for the detection of SARS-CoV-2: A comment
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Rapid antigen test for SARS-CoV-2 and primary health care
por: Fernández-Villa, T., et al.
Publicado: (2021)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Non-epileptic myoclonus status can be due to both SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2023)

SARS-CoV-2 related myocardial injury might explain the predisposition to preeclampsia with maternal SARS-CoV-2 infection
por: Giorgione, Veronica, et al.
Publicado: (2022)

Transmission routes for SARS-CoV-2 infection: review of evidence
por: Falahi, S., et al.
Publicado: (2020)

Intrauterine vertical transmissibility of SARS-CoV-2: the evidence is evolving
por: Penfield, Christina A., et al.
Publicado: (2020)

Ample evidence suggests SARS-CoV-2 triggers polyradiculitis
por: Finsterer, J., et al.
Publicado: (2022)

Ample evidence suggests SARS-CoV-2 triggers polyradiculitis
por: Finsterer, J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s8pk9930jqcu75h188r8ck88vr